PMED — Predictmedix AI Cashflow Statement
0.000.00%
- CA$15.56m
- CA$15.45m
- 14
- 34
- 78
- 37
Annual cashflow statement for Predictmedix AI, fiscal year end - January 31st, CAD millions except per share, conversion factor applied.
2021 January 31st | 2022 January 31st | 2023 January 31st | 2024 January 31st | 2025 January 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1.58 | -1.88 | -2.07 | -1.99 | -1.18 |
| Depreciation | |||||
| Non-Cash Items | 0.579 | 0.219 | 0.518 | 0.365 | 0.191 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.078 | 0.051 | 0.856 | -0.182 | 0.792 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -1.08 | -1.53 | -0.534 | -1.64 | -0.037 |
| Capital Expenditures | -0.195 | -0.418 | -0.145 | 0 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0 | — | — | — | — |
| Sale of Business | |||||
| Cash from Investing Activities | -0.195 | -0.418 | -0.145 | 0 | — |
| Financing Cash Flow Items | 0 | -0.004 | -0.033 | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.261 | 1.68 | 0.547 | 1.6 | 0 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1.01 | -0.269 | -0.132 | -0.042 | -0.037 |